Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo

被引:31
作者
Agvald, P [1 ]
Adding, LC
Gustafsson, LE
Persson, MG
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, Div Physiol, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
关键词
organic nitrate; vasodilator agent; drug tolerance; tachyphylaxis; nitric oxide (NO);
D O I
10.1016/S0014-2999(99)00720-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitric oxide (NO) increments in exhaled air and changes in mean arterial pressure of anaesthetised rabbits were measured in order to study the NO generation from NO donors and tachyphylaxis in NO formation from nitroglycerin. Continuous infusions of isosorbide dinitrate, isosorbide-5-mononitrate and 3-morpholino-sydnonimine (SIN-1) evoked dose-dependent increases in exhaled NO, paralleled by decrements in mean arterial pressure. Repeated infusions of nitroglycerin resulted in attenuation (P < 0.01) of the NO increase from a given dose. Concurrent infusions of isosorbide dinitrate, isosorbide-5-mononitrate or nitroglycerin reduced the amount of NO emanating from the bioconversion of a given dose nitroglycerin as measured in the expired air (P < 0.01 for all drugs), indicating cross-tachyphylaxis. SIN-1 did not exhibit such cross-tachyphylaxis. In conclusion, measurements of exhaled NO can be a useful tool for exploration of nitrovasodilator tachyphylaxis. Cross-tachyphylaxis is only shared between some nitrovasodilators and is possibly not due to feedback from the generated NO. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 2006, J PHYSIOL-LONDON, DOI DOI 10.1113/jphysiol.2006.116632
[2]   RELATIONSHIP BETWEEN NITROGLYCERIN, CYCLIC-GMP AND RELAXATION OF VASCULAR SMOOTH-MUSCLE [J].
AXELSSON, KL ;
WIKBERG, JES ;
ANDERSSON, RGG .
LIFE SCIENCES, 1979, 24 (19) :1779-1786
[3]   PERSISTENCE OF THE RESPONSE TO SIN1 ON ISOLATED CORONARY-ARTERIES RENDERED TOLERANT TO NITROGLYCERIN INVITRO OR INVIVO [J].
BERKENBOOM, G ;
FONTAINE, J ;
DEGRE, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (03) :345-349
[4]  
BOEGART MG, 1968, ARCH INT PHARMACOD T, V171, P221
[5]  
BOHME E, 1982, MOLSIDOMIN NEUE ASPE, P37
[6]   NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE [J].
BOLOTINA, VM ;
NAJIBI, S ;
PALACINO, JJ ;
PAGANO, PJ ;
COHEN, RA .
NATURE, 1994, 368 (6474) :850-853
[7]   BIOACTIVATION OF NITROGLYCERIN IN VASCULAR SMOOTH-MUSCLE CELLS IS DIFFERENT FROM THAT IN NONVASCULAR TISSUE [J].
BRAUN, M ;
GROSSER, T ;
SCHROR, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 276 (03) :239-245
[8]   DIRECT DEMONSTRATION OF NO FORMATION IN-VIVO FROM ORGANIC NITRITES AND NITRATES, AND CORRELATION TO EFFECTS ON BLOOD-PRESSURE AND TO IN-VITRO EFFECTS [J].
CEDERQVIST, B ;
PERSSON, MG ;
GUSTAFSSON, LE .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (06) :1047-1053
[9]  
CHUNG SJ, 1993, BIOCHEM PHARMACOL, V45, P157
[10]   BIOTRANSFORMATION OF ORGANIC NITRATES TO NITRIC-OXIDE BY VASCULAR SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS [J].
FEELISCH, M ;
KELM, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (01) :286-293